... from ongoing Phase 2 MARIO-3 Trial at San Antonio Breast Cancer Symposium. ... Aytu Bioscience, last week, disclosed it established purchasing relationship with ... Oncolytics Biotech Inc. (NASDAQ: ONCY) fell 17.4% to $3.17.
News
- 52 Stocks Moving In Wednesday's Mid-Day Session
- News briefing: Assembly Bio scraps microbiome programs; InveniAI, Kyowa Kirin expand ...
Assembly Biosciences said the decision was “not based on any efficacy, ... The 21-year-old, New York-based biotech announced Phase I data for its gene ... unveiled Wednesday at the virtual San Antonio Breast Cancer Symposium.
- RA Capital backs Oxford spinout PepGen with a $45M Series A, seeking to treat Duchenne and ...
The biotech says that the cell-penetrating nature of the peptides, when ... unveiled Wednesday at the virtual San Antonio Breast Cancer Symposium.
- PharmAbcine presents the latest data of the ongoing Phase Ib mTNBC trial at SABCS 2020
The results were presented at the SABCS (San Antonio Breast Cancer ... PharmAbcine is a clinical-stage biotech company focusing on the ...
- BriaCell Presents Clinical Data at the 2020 San Antonio Breast Cancer Symposium®
("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB: BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapies for ...